In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant staphylococcus aureus

Foodborne Pathogens and Disease

Volumn 8, Issue 8, 2011, Pages 869-874

  Obiang Obounou, Brice Wilfried ^a   Kang, Ok Hwa ^a   Choi, Jang Gi ^a,b   Keum, Joon Ho ^a   Kim, Sung Bae ^a   Mun, Su Hyun ^a   Shin, Dong Won ^c   Park, Chung Berm ^d   Kim, Young Guk ^d   Han, Sin Hee ^d   Lee, John Hwa ^b   Kwon, Dong Yeul ^a  

^a Wonkwang University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Sunchon National University   (South Korea)

^d Rural Development Administration   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; NORFLOXACIN; OXACILLIN; SANGUINARINE; VANCOMYCIN;

ARTICLE; ASSAY; BACTERIAL COUNT; BACTERIAL STRAIN; BROTH DILUTION; COLONY FORMING UNIT; DRUG EFFICACY; DRUG POTENTIATION; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL LOAD; BENZOPHENANTHRIDINES; CIPROFLOXACIN; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ISOQUINOLINES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NORFLOXACIN; OXACILLIN; SPECIES SPECIFICITY; VANCOMYCIN;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 79960521307     PISSN: 15353141     EISSN: 15567125     Source Type: Journal    
DOI: 10.1089/fpd.2010.0759     Document Type: Article

References (26)

1. Abate G, Mshana RN, and Miorner H. Evaluation of a colori-metric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-nyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1998;2:1011-1016. (Pubitemid 29005219)
2. Aqil F, Ahmad I, and Owais M. Evaluation of anti-methicillin-resistant Staphylococcus aureus (MRSA) activity and synergy of some bioactive plant extracts. Biotechnol J 2006;1:1093-1102.
3. Baltch AL, Ritz WJ, Bopp LH, Michelsen PB, and Smith RP. Antimicrobial activities of daptomycin, vancomycin, and ox-acillin in human monocytes and of daptomycin in combina-tion with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus. Antimicrob Agents Chemother 2007;51:1559-1562. (Pubitemid 46586853)
4. Bycroft BW and Shute R The molecualr basis for the mode of action of beta-lactam antibiotics and mechamism of resistance. Pharm Res 1985;3-14. (Pubitemid 15154355)
5. Choi JG, Kang OH, Obiang-Obounou B, Lee YS, Chae HS, Oh YC, Sohn DH, Park H, Choi HG, Kim SG, Shin DW, and Kwon DY. Antibacterial activity of Ecklonia cava against methicillin-resistant Staphylococcus aureus and Salmonella spp. Foodborne Pathog Dis 2010;7:435-441.
6. Ciancio, SG. Agents for the management of plaque and gingi-vitis. J Dent Res 1992;71,1450-1454.
7. [CLSI] Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards. CLSI document M7-A5. Wayne, PA: CLSI, 2000.
8. Dancer SJ. The effect of antibiotics on methicillin-resistant Sta-phylococcus aureus. J Antimicrob Chemother 2008;61:246-253.
9. Drago L, De Vecchi E, Nicola L, and Gismondo MR In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infect Dis 2007;7:111.
10. Drlica K and Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997;377-392. (Pubitemid 28090230)
11. Dzink JL and Socransky SS. Comparative in vitro activity of sanguinarine against oral microbial isolates. Antimicrob Agents Chemother 1985;27:663-665. (Pubitemid 15097684)
12. Gibbons S. Anti-staphylococcal plant natural products. Nat Prod Rep 2004;21:263-277. (Pubitemid 38527319)
13. Grenby TH. The use of sanguinarine in mouthwashes and toothpaste compared with some other antimicrobial agents. Br Dent J 1995;178:254-258.
14. Howell CR, Stipanovic RD, and Bell AA. Dihydrosanguinarine, a product of sanguinarine detoxification by Verticillium dahlia. Pesticide Biochem Physiol 1972;2:364-370.
15. Hussy P, Maass G, Tümmler B, Grosse F, and Schomburg U. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob. Agents Chemother 1986;29:1073-1078. (Pubitemid 16084072)
16. Kastoris AC, Rafailidis PI, Vouloumanou EK, Gkegkes ID, and Falagas ME. Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Eur J Clin Phar-macol 2010;66:359-368.
17. Kim S, Lee TJ, Leem J, Choi KS, Park JW, and Kwon TK. Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. J Cell Biochem 2008;104:895-907. (Pubitemid 351830838)
18. Kwon DY, Kang OH, Choi JG, Lee YS, Oh YC, Chae HS, Lee GH, Park PS, Kim YC, Sohn DH, Park H, and Lee JH. Antibacterial effect of Dryopteris crassirhizoma against methicillin-resistant Staphylococcus aureus. Fitoterapia 2007;78:430-433. (Pubitemid 47284674)
19. Lee YS, Kang OH, Choi JG, Oh YC, Chae HS, Kim JH, Park H, Sohn DH, Wang ZT, and Kwon DY. Synergistic effects of the combination of galangin with gentamicin against methicillin-resistant Staphylococcus aureus. J Microbiol 2008;46:283-288. (Pubitemid 351951116)
20. Liu IX, Durham DG, and Richards RM. Baicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylo-coccus aureus and other beta-lactam-resistant strains of S. au-reus. J Pharm Pharmacol 2000;52:361-366. (Pubitemid 30189394)
21. Miranda-Novales G, Leaños-Miranda BE, Vilchis-Pérez M, and Solórzano-Santos F. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and ami-kacin against methicillin-resistant Staphylococcus spp. strains. Ann Clin Microbiol Antimicrob 2006;5:25.
22. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003;52:1. (Pubitemid 36850074)
23. Pitts BJR and Meyerson LR. Inhibition of Na, K-ATPase activity and ouabain binding by sanguinarine. Drug Dev Res 1981;1:43-49. (Pubitemid 11005878)
24. Scheuber PH, Scheuber PH, Mossmann H, Beck G, and Hammer DK. Direct skin test in highly sensitized guinea pigs for rapid and sensitive determination of staphylococcal enterotoxin B. Appl Environ Microbiol 1983;46:1351-1356. (Pubitemid 14223946)
25. Shi YJ, Chen J, and Xu M. A new method for antimicrobial susceptibility testing of in vitro-cultured bacteria by means of resonance light scattering technique. J Microbiol Biotechnol 2008;18:118-123.
26. Vidaillac C, Leonard SN, and Rybak MJ. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA) isolates. Int J Antimicrob Agents 2010;35:527-530.